Home > Healthcare > Pharmaceuticals > Finished Drug Form > Orthobiologics Market

Orthobiologics Market Trends

  • Report ID: GMI9311
  • Published Date: Apr 2024
  • Report Format: PDF

Orthobiologics Market Trends

The growing preference for minimally invasive procedures (MIS) is a key driver of the market globally. Patients and healthcare providers increasingly favour MIS due to its numerous benefits, including reduced trauma, shorter recovery times, and lower risk of complications.

  • Technological advancements have played a significant role in driving the adoption of MIS and subsequently fueling the demand for orthobiologics. For example, the development of advanced imaging techniques, such as fluoroscopy and ultrasound, enables surgeons to accurately visualize anatomical structures and perform procedures with greater precision.
  • Additionally, the introduction of minimally invasive surgical instruments and devices, such as arthroscopic tools and robotic-assisted systems, has facilitated the execution of complex orthopedic devices and procedures through smaller incisions.
  • Moreover, healthcare systems worldwide seek to optimize resource utilization and improve patient outcomes, there is a growing incentive to adopt MIS techniques and incorporate orthobiologic products that support these approaches.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Orthobiologics market size was valued at USD 6.8 billion in 2023 and is estimated to grow at 5.7% CAGR from 2024 to 2032, driven by the increasing prevalence of orthopedic disorders.

The hospitals and orthopedic clinics segment in the orthobiologics industry will generate USD 7.6 billion by 2032, due to the strong need for handling joint reconstruction devices, spinal fusion devices, and soft tissue repair.

North America orthobiologics market size accounted for USD 3 billion in revenue in 2023, owing to the prevalence of individuals participating in sports and physical activities and higher incidence of sports-related injuries.

Anika Therapeutics, Inc., Arthrex Inc., Bioventus LLC, Depuy Synthes (JnJ), Globus Medical Inc., Medtronic PLC, NuVasive Inc., Orthofix Medical Inc., RTI Surgical, Seaspine Holdings Corporation, Stryker Corporation and Zimmer Biomet

Orthobiologics Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 149
  • Countries covered: 23
  • Pages: 100
 Download Free Sample